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Abstract:  
Drug absorption in the gastrointestinal tract is a highly variable process. Floating microspheres are promises 
to be a potential approach for gastric retention enhances the bioavailability and controlled delivery of various 
therapeutic agents. Significant attempts have been made worldwide to explore these systems according to 
patient requirements, both in terms of therapeutic efficacy and compliance. Floating microspheres as gastro 
retentive dosage forms precisely control the release rate of target drug to a specific site and facilitate an 
enormous impact on health care. These systems also provide tremendous opportunities in the designing of new 
controlled and delayed release oral formulations, thus extending the frontier of futuristic pharmaceutical 
development. Furthermore, recent innovations in pharmaceutical investigation will surely provide real 
prospects for establishment of novel and effective means in the development of these promising drug delivery 
systems.  
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INTRODUCTION: 
Gastroretentive Drug Delivery System: Oral 
controlled release (CR) dosage forms (DFs) have 
been developed over the past three decades due to 
their considerable therapeutic advantages such as 
ease of administration, patient compliance and 
flexibility in formulation. However, this approach 
is bedilled with several physiological difficulties 
such as inability to restrain and locate the 
controlled drug delivery system within the desired 
region of gastrointestinal tract (GIT) due to 
variable gastric emptying and motility [1-4]. 
Furthermore, the relatively brief gastric emptying 
time (GET) in humans which normally averages 2-
3 h through the major absorption zone, i.e., 
stomach and upper part of the intestine, can result 
in incomplete drug release from the drug delivery 
system leading to reduced efficacy of the 
administered dose. Therefore, control on placement 
of a variety of important drugs through 
appropriately designed drug delivery system (DDS) 
in a specific region of the GI tract offers 
advantages particularly for those having a narrow 
absorption window in the GIT or those with 
stability problems. These considerations have led to 
the development of a unique oral controlled release 
dosage form with Gastroretentive properties. After 
oral administration, such a DF would be retained in 
the stomach and release the drug there in a 
controlled and prolonged manner so that the drug 
could be supplied continuously to its absorption 
sites in the upper gastrointestinal tract. 
Gastroretentive dosage form can remain in the 
gastric region for several hours and hence 
significantly prolong the gastric residence time of 
drugs. Prolonged gastric retention improves 
bioavailability, reduces drug waste and improves 
solubility of drugs that are less soluble in a high pH 
environment. It is also suitable for local drug 
delivery to the stomach and proximal small 
intestine [6-10]. 
Gastric emptying is a complex process, one that is 
highly variable and that makes in vivo performance 
of drug delivery systems uncertain. A controlled 
drug delivery system with prolonged residence time 
in the stomach can be of great practical importance 
for drugs with an absorption window in the upper 
small intestine. Floating or hydrodynamically 
controlled drug delivery systems are useful in such 
applications. Various gastroretentive dosage forms 
are available, including tablets, capsules, pills, 
laminated films, floating microspheres, granules 
and powders. The dosage form comprises a 
plurality of buoyant particles, each comprising an 
inner drug-containing core, an intermediate layer 
surrounding said core and a release rate-controlling  
 
outer coating. Floating microspheres have been 
gaining attention due to the uniform distribution of 
these multiple-unit dosage forms in the stomach, 
which results in more reproducible drug absorption 
and reduced risk of local irritation. 
 
 
 
 
 
 
Figure 1: Drug blood level versus time profiles 
 
Mechanism: 
Most of the floating systems  are single-unit 
systems, which are generally unreliable and non-
reproducible in prolonging the GRT, in virtue of 
their unpredictable all-or-nothing emptying 
process. On the other hand, multiple-unit dosage 
forms appear to be better suited, since they claim to 
reduce inter-subject variability in absorption and 
have a lower dose-dumping probability. The 
uniform distribution of these multiple unit dosage 
forms along the GIT could result in more 
reproducible drug absorption and reduced risk of 
local irritation; this gave way to the development of 
gastroretentive floating microspheres [11-13] 
Floating microspheres are gastroretentive drug 
delivery systems based on a non-effervescent 
approach. Hollow microspheres, microballoons or 
floating microparticles are terms used 
synonymously for floating microspheres. Floating 
microspheres are, in a strict sense, spherical empty 
particles without a core. These are free-flowing 
particles, with size ranging from 1 to 1000 µm. 
non-effervescent hollow polycarbonate 
microspheres are developed  by using an emulsion 
solvent evaporation method. This gastrointestinal 
transit-controlled preparation is designed to float on 
gastric juice with a specific density of less than 
one. This property results in delayed transit through 
the stomach. The drug is released slowly at desired 
rate, resulting in increased gastric retention with 
reduced fluctuations in plasma drug concentration 
[14]. 
Advantages of floating microspheres: 
1. Bioavailability enhances, despite first pass 
effect, because fluctuations in plasma drug 
concentration are avoided, and a desirable plasma 
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drug concentration is maintained by continuous 
drug release. 
2. Superior to single-unit floating dosage forms, as 
such microspheres release drugs uniformly and 
there is no risk of dose dumping. 
3. Enhanced absorption of drugs that solubilise 
only in stomach. 
4. Site-specific drug delivery to the stomach can be 
achieved. 
5. Avoidance of gastric irritation, due to sustained 
release effect. 
6. Better therapeutic effect of short half-life drugs 
can be achieved. 
Disadvantage 
Reproducibility of the particle size of the 
formulation. 
Methods of Preparation of Hollow 
Microspheres: 
Hollow microspheres are prepared through 
the solvent diffusion and evaporation method to 
create the hollow inner core. The solvent is 
evaporated either by increasing the temperature 
under pressure or by continuous stirring. 
The floating microspheres are prepared by the 
emulsion solvent diffusion method, utilizing enteric 
acrylic polymers dissolved with drug in a mixture 
of dichloromethane and ethanol. The above 
solution was introduced in the aqueous solution of 
polyvinyl alcohol at 40 ºC with constant stirring to 
form an oil-in-water (o/w) emulsion. After 
agitating the system for 1 hour, the resulting 
polymeric particulate systems were sieved between 
500 and 1000 mm and then dried overnight at 40 ºC 
to produce hollow microspheres. 
A novel two step manufacturing process of  hollow, 
poly-butyl-2-cyanoacrylate (PBCA) microspheres 
in an aqueous phase was developed to synthesize 
gas-filled hollow microspheres. These 
microspheres have an organic shell. The first step is 
the polymerization process of n-butyl-2- 
cyanoacrylate (BCA) to form nanoparticles. During 
the second step, the nanoparticles attach on a 
microbubble precursor and finally form hollow 
microspheres. 
Cellulose acetate, chitosan, Eudragit, Acrycoat, 
Methocel, polyacrylates, polyvinyl acetate, 
Carbopol, agar, polyethylene oxide, 
polycarbonates, acrylic resins and polyethylene 
oxide are some of the polymers used in the 
preparation of hollow microspheres. 
 Mechanism of formation of hollow 
microspheres 
Ethanol and methanol have been found to be good 
solvents for most drugs and polymers. 
Dichloromethane and chloroform are good bridging 
liquids due to the good linkage between the drug 
and polymers and to their immiscibility in the 
external phase. Water-insoluble polymers, 
mentioned above, show higher solubility in 
dichloromethane than ethanol. However, ethanol 
has higher solubility in water. As soon as the 
polymer solution was added to the aqueous 
medium, the ethanol diffuses rapidly from the 
droplets of the polymer solution. Simultaneous 
diffusion of water inside the sphere further 
decreased the ethanol concentration, hence the 
polymer precipitated, resulting in the formation of 
microspheres. Dichloromethane remaining as the 
central core diffused slowly due to its low water 
solubility. Therefore, the diffusion of ethanol 
played an important role in determining the size 
and shape of the microspheres. 
 
Mechanism of gastro retention 
When microspheres come in contact with gastric 
fluid, the gel formers, polysaccharides, and 
polymers hydrate to form a colloidal gel barrier that 
controls the rate of fluid penetration into the device 
and drug release. As the exterior surface of the 
dosage form dissolves, the gel layer is maintained 
by the hydration of the adjacent hydrocolloid layer. 
The air trapped by the swollen polymer lowers the 
density and confers buoyancy to the microspheres. 
However, a minimal gastric content is needed to 
allow proper achievement of buoyancy. 
Characterization/evaluation of floating 
microspheres 
Particle size 
Size is measured using an optical microscope, and 
mean particle size is calculated by measuring 200–
300 particles with the help of a calibrated ocular 
micrometer 
Tapped density and compressibility index 
The tapping method is used to determine the tapped 
density and percentage compressibility index, as 
follows  
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where V and Vo are the volumes of the sample after 
and before the standard tapping, respectively. 
Floating behaviour 
The floating test on the microspheres is carried out 
using the dissolution method II apparatus, specified 
in the USP XXII. The microspheres are spread over 
the surface of the dispersing medium (900 ml), 
which is agitated by a paddle rotated at 100 rpm. 
Disintegration test solution No. 1 (pH 1.2), 
containing Tween 20 (0.02%, w/v), is used as a 
dispersing medium to simulate gastric fluid. After 
agitation for a previously determined interval, the 
hollow microspheres that floated over the surface 
of medium and those that settled to the bottom of 
the flask are recovered separately. After drying, 
each fraction of the hollow microspheres is 
weighed. The buoyancy of the hollow microspheres 
is represented by the following equation. 
 
where Qf and Qs are the weights of the floating and 
settled hollow microspheres, respectively. 
In vitro release studies 
In vitro dissolution studies can be carried out in a 
USP paddle type dissolution assembly. 
Microspheres equivalent to the drug dose are added 
to 900 ml of the dissolution medium and stirred at 
100 rpm at 37 ± 0.5 ºC. Samples are withdrawn at a 
specified time interval and analyzed by any suitable 
analytical method, such as UV spectroscopy or 
HPLC, etc. 
In vivo studies 
In vivo studies are generally conducted in healthy 
male albino rabbits weighing 2-2.5 kg. The animals 
are fasted for 24 hours before the experiments; 
however, they are given free access to food and 
water during the experiments. Blood samples (2 
mL) are collected from the marginal ear vein into 
heparinized centrifuge at an appropriate time 
interval 
Applications of floating microspheres 
1. Floating microspheres can be used as carriers for 
drugs with so-called absorption windows 
 for example antiviral, antifungal and antibiotic 
agents (sulphonamides, quinolones, penicillins, 
cephalosporins, aminoglycosides and tetracyclines) 
are taken up only from very specific sites of the GI 
mucosa. 
2. Hollow microspheres of non-steroidal anti-
inflammatory drugs are very effective for 
controlled release, and reduce the major side effect 
of gastric irritation. For example, floating 
microspheres of indomethacin are quite beneficial 
for rheumatic patients. 
3. Floating microspheres are especially effective in 
the delivery of sparingly soluble and insoluble 
drugs. It is known that as the solubility of a drug 
decreases, the time available for drug dissolution 
becomes less adequate, and thus transit time 
becomes a significant factor affecting drug 
absorption. 
4.  The gastroretentive floating microspheres will 
beneficially alter the absorption profile of the 
active agent, thus enhancing its bioavailability. 
5. Hollow microspheres can greatly improve the 
pharmacotherapy of the stomach through local drug 
release, leading to high drug concentrations at the 
gastric mucosa, thus eradicating Helicobacter 
pylori from the sub-mucosal tissue of the stomach 
and making it possible to treat stomach and 
duodenal ulcers, gastritis and oesophagitis.  
CONCLUSION:  
Floating microspheres has emerged as an efficient 
approach for enhancing the bioavailability and 
controlled delivery of various therapeutic agents. 
Significant attempts have been made worldwide to 
explore these systems according to patient 
requirements, both in terms of therapeutic efficacy 
and compliance. Floating microspheres as gastro 
retentive dosage forms precisely control the release 
rate of target drug to a specific site and facilitate an 
enormous impact on health care. Optimized multi-
unit floating microspheres are expected to provide 
clinicians with a new choice of an economical, safe 
and more bioavailable formulation in the effective 
management of diverse diseases. These systems 
also provide tremendous opportunities in the 
designing of new controlled and delayed release 
oral formulations, thus extending the frontier of 
futuristic pharmaceutical development. Increased 
sophistication of this system will ensure the 
successful advancements in the avenue of gastro 
retentive microspheres therapy so as to optimize 
the delivery of molecules in a more efficient 
manner.  
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